G
Generate Biomedicines Inc
NASDAQ:GENB
Generate Biomedicines Inc
NASDAQ:GENB
Price:
13.12
USD
0.23%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Generate Biomedicines Inc
NASDAQ:GENB
|
US |
|
S
|
Saputo Inc
XBER:SB7
|
CA |
|
T
|
Talanx AG
XBER:TLX
|
DE |
|
Aftermath Silver Ltd
F:FLM1
|
CA |
|
M
|
Medios AG
F:ILM1
|
DE |
|
Australian Strategic Materials (Holdings) Ltd
ASX:ASM
|
AU |
|
N
|
Nichirei Corp
XBER:NI3
|
JP |
|
CE Info Systems Ltd
BSE:543425
|
IN |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
Liquidia Corp
F:LT4
|
US |
|
T
|
Talisker Resources Ltd
OTC:TSKFF
|
CA |
|
Thule Group AB
OTC:THLPF
|
SE |
|
D
|
Diginex Ltd
NASDAQ:DGNX
|
HK |
|
E
|
Electromagnetic Geoservices ASA
XMUN:E2M
|
NO |
|
WM Technology Inc
OTC:MAPS
|
US |
|
Deutsche Lufthansa AG
F:LHA
|
DE |
Wall St Price Targets
GENB Price Targets Summary
Generate Biomedicines Inc
Generate Biomedicines Inc
Wall Street analysts forecast GENB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for GENB is 24.23 USD with a low forecast of 20.2 USD and a high forecast of 27.3 USD.
Lowest Forecast
Price Target
20.2
USD
54% Upside
Average Forecast
Price Target
24.23
USD
85% Upside
Highest Forecast
Price Target
27.3
USD
108% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GENB's stock price target?
Price Target
24.23
USD
24.23
USD
According to Wall Street analysts, the average 1-year price target for GENB is 24.23 USD with a low forecast of 20.2 USD and a high forecast of 27.3 USD.
What is the Revenue forecast for Generate Biomedicines Inc?
Projected CAGR
58%
58%
The compound annual growth rate for Revenue over the next 8 years is 58%.
